These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 37805654)

  • 21. Maternal knowledge, attitudes and beliefs regarding gastroenteritis and rotavirus vaccine before implementing vaccination program: which key messages in light of a new immunization program?
    Morin A; Lemaître T; Farrands A; Carrier N; Gagneur A
    Vaccine; 2012 Sep; 30(41):5921-7. PubMed ID: 22858556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using big data to analyze the vaccination status of children with congenital heart disease in Yinzhou District, China.
    Zhang L; Yang Z; Yin Y; Huang W; Yi T; Ping J; Liu L; Shen P; Sun Y; Lin H
    Hum Vaccin Immunother; 2024 Dec; 20(1):2319967. PubMed ID: 38465660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of rotavirus vaccination on acute diarrhea in Thai children under 5 years of age in the first year of universal implementation of rotavirus vaccines in the National Immunization Program (NIP) in Thailand: a 6-year analysis.
    Charoenwat B; Suwannaying K; Paibool W; Laoaroon N; Sutra S; Thepsuthammarat K; Sirirattanakul S
    BMC Public Health; 2023 Oct; 23(1):2109. PubMed ID: 37891542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uptake and timeliness of rotavirus vaccination in Norway: The first year post-introduction.
    Valcarcel Salamanca B; Hagerup-Jenssen ME; Flem E
    Vaccine; 2016 Sep; 34(39):4684-4689. PubMed ID: 27522178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prioritization of the introduction of new vaccines to the national immunization program in the Republic of Korea.
    Choe YJ; Han OP; Cho H; Bae GR; Chun BC; Kim JH; Kim KH; Lee HJ; Choi EH
    Vaccine; 2014 Oct; 32(46):6049-53. PubMed ID: 25239482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccine hesitancy and receipt of mandatory and optional pediatric vaccines in Shanghai, China.
    Ji M; Huang Z; Ren J; Wagner AL
    Hum Vaccin Immunother; 2022 Nov; 18(5):2043025. PubMed ID: 35321621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uptake of oral rotavirus vaccine and timeliness of routine immunization in Brazil's National Immunization Program.
    Flannery B; Samad S; de Moraes JC; Tate JE; Danovaro-Holliday MC; de Oliveira LH; Rainey JJ
    Vaccine; 2013 Mar; 31(11):1523-8. PubMed ID: 23313652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Public subsidies and the recommendation of child vaccines among primary care physicians: a nationwide cross-sectional study in Japan.
    Sakanishi Y; Yamamoto Y; Hara M; Fukumori N; Goto Y; Kusaba T; Tanaka K; Sugioka T; Vaccine Project Team JPCA; Fukuhara S
    BMJ Open; 2018 Jul; 8(7):e020923. PubMed ID: 30030315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parental preference for Haemophilus influenzae type b vaccination in Zhejiang Province, China: A discrete choice experiment.
    Wang X; Feng Y; Zhang Q; Ye L; Cao M; Liu P; Liu S; Li S; Zhang J
    Front Public Health; 2022; 10():967693. PubMed ID: 36466507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunization delivery in the second year of life in Ghana: the need for a multi-faceted approach.
    Nyaku M; Wardle M; Eng JV; Ametewee L; Bonsu G; Larbi Opare JK; Conklin L
    Pan Afr Med J; 2017; 27(Suppl 3):4. PubMed ID: 29296139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of immunization status in patients with cerebral palsy: a multicenter CP-VACC study.
    Bozkaya-Yilmaz S; Karadag-Oncel E; Olgac-Dundar N; Gencpinar P; Sarioglu B; Arican P; Ersen A; Yilmaz-Ciftdoğan D; Yuksel MF; Bektas O; Teber S; Kilic B; Calik M; Karaca M; Canpolat M; Kumandas S; Per H; Gumus H; Ozturk S; Okuyaz C; Komur M; Ipek R; Ozbudak P; Arhan E; Ince H; Gurbuz G; Mert GG; Ozcan N; Turker AO; Gazeteci-Tekin H; Kırık S; Günbey C; Çarman KB; Yarar C; Çavuşoğlu D
    Eur J Pediatr; 2022 Jan; 181(1):383-391. PubMed ID: 34355277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High cost is the primary barrier reported by physicians who prescribe vaccines not included in India's Universal Immunization Program.
    Kahn GD; Thacker D; Nimbalkar S; Santosham M
    J Trop Pediatr; 2014 Aug; 60(4):287-91. PubMed ID: 24567310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of uptake of newly introduced vaccines in Malawi - monovalent human rotavirus and pneumococcal conjugate vaccines: Evidence from the 2015-16 Malawi demographic and health survey.
    Ntenda PAM; Mwenyenkulu ET; Putthanachote N; Nkoka O; Mhone TG; Motsa MPS; Tizifa T
    J Trop Pediatr; 2019 Jun; 65(3):287-296. PubMed ID: 30085260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High pneumonia lifetime-ever incidence in Beijing children compared with locations in other countries, and implications for national PCV and Hib vaccination.
    Qu F; Weschler LB; Sun Y; Sundell J
    PLoS One; 2017; 12(2):e0171438. PubMed ID: 28166256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and factors associated with pentavalent vaccination: a cross-sectional study in Southern China.
    Xu J; Cui Y; Huang C; Dong Y; Zhang Y; Fan L; Li G; Jiang F
    Infect Dis Poverty; 2023 Sep; 12(1):84. PubMed ID: 37715293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parental knowledge, attitudes and perception of pneumococcal disease and pneumococcal conjugate vaccines in Singapore: a questionnaire-based assessment.
    How CH; Phua See Chun P; Shafi F; Jakes RW
    BMC Public Health; 2016 Sep; 16(1):923. PubMed ID: 27590503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenicity and safety of a novel ten-valent pneumococcal conjugate vaccine in healthy infants in The Gambia: a phase 3, randomised, double-blind, non-inferiority trial.
    Clarke E; Bashorun A; Adigweme I; Badjie Hydara M; Umesi A; Futa A; Ochoge M; Obayemi D; Edem B; Saidy-Jah E; Onwuchekwa C; Dhere R; Sethna V; Kampmann B; Goldblatt D; Taylor D; Andi-Lolo I; Hosken N; Antony K; Innis BL; Alderson MR; Lamola S
    Lancet Infect Dis; 2021 Jun; 21(6):834-846. PubMed ID: 33516293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utilization pattern of Haemophilus influenza type b vaccine in eight provinces of China.
    Li Y; Yue C; Wang Y; Zhu X; Martin K; Scherpbier RW; Liu J; Wang Z; Ma Y; Cheng H; Zhang Z; Wang Q; Li H; Xie S; Xiao Q; Wang H; An Z
    Hum Vaccin Immunother; 2018 Apr; 14(4):894-899. PubMed ID: 29300680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunogenicity and safety of the Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine co-administered with human rotavirus, hepatitis A and 13-valent pneumococcal conjugate vaccines: results from a phase III, randomized, multicenter study in infants.
    Klein NP; Abu-Elyazeed R; Baine Y; Cheuvart B; Silerova M; Mesaros N
    Hum Vaccin Immunother; 2019; 15(2):327-338. PubMed ID: 30252603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Streptococcus pneumoniae and Haemophilus influenzae type b carriage in Chinese children aged 12-18 months in Shanghai, China: a cross-sectional study.
    Hu J; Sun X; Huang Z; Wagner AL; Carlson B; Yang J; Tang S; Li Y; Boulton ML; Yuan Z
    BMC Infect Dis; 2016 Apr; 16():149. PubMed ID: 27080523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.